Back to Search
MARC ERNSTOFF, MD
MD
Medical Oncology Physician
NPI: 1275549073Individual
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
138461(NY)
Research & Publications (20)
A pooled analysis of melanocytic nevus phenotype and the risk of cutaneous melanoma at different latitudes.
PMID 18792098·Int J Cancer·2009
8-other
Clinical and immunologic effects of intranodal autologous tumor lysate-dendritic cell vaccine with Aldesleukin (Interleukin 2) and IFN-{alpha}2a therapy in metastatic renal cell carcinoma patients.
PMID 19622576·Clin Cancer Res·2009
3-trial
Sun exposure and melanoma risk at different latitudes: a pooled analysis of 5700 cases and 7216 controls.
PMID 19359257·Int J Epidemiol·2009
8-other
Ex vivo expansion of tumor specific lymphocytes with IL-15 and IL-21 for adoptive immunotherapy in melanoma.
PMID 19501956·Cancer Lett·2009
8-other
Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes.
PMID 19201693·Cancer Res·2009
7-preclinical
Temozolomide, thalidomide, and whole brain radiation therapy for patients with brain metastasis from metastatic melanoma: a phase II Cytokine Working Group study.
PMID 18792064·Cancer·2008
3-trial
Tracking antigen-driven responses by flow cytometry: monitoring proliferation by dye dilution.
PMID 18785636·Cytometry A·2008
8-other
Exposure to sunlamps, tanning beds, and melanoma risk.
PMID 18273687·Cancer Causes Control·2008
8-other
Three phase II cytokine working group trials of gp100 (210M) peptide plus high-dose interleukin-2 in patients with HLA-A2-positive advanced melanoma.
PMID 18467720·J Clin Oncol·2008
3-trial
Enhanced efficacy and reduced toxicity of multifactorial adjuvants compared with unitary adjuvants as cancer vaccines.
PMID 18202224·Blood·2008
4-observational
The clinical pharmacology of therapeutic monoclonal antibodies in the treatment of malignancy; have the magic bullets arrived?
PMID 18503606·Br J Clin Pharmacol·2008
6-review
Radiation therapy and sorafenib: clinical data and rationale for the combination in metastatic renal cell carcinoma.
PMID 17553211·Clin Genitourin Cancer·2007
5-case
Report on the ISBTC mini-symposium on biologic effects of targeted therapeutics.
PMID 17667521·J Immunother·2007
6-review
Phase I trial of BAY 50-4798, an interleukin-2-specific agonist in advanced melanoma and renal cancer.
PMID 17545537·Clin Cancer Res·2007
3-trial
Factors associated with atypical moles in New Hampshire, USA.
PMID 17225015·Acta Derm Venereol·2007
4-observational
Innovations and challenges in renal cell carcinoma: summary statement from the Second Cambridge Conference.
PMID 17255291·Clin Cancer Res·2007
6-review
Developing a rational tumor vaccine therapy for renal cell carcinoma: immune yin and yang.
PMID 17255302·Clin Cancer Res·2007
6-review
Early recovery of aggressive cytotoxic cells and improved immune resurgence with post-transplant immunotherapy for multiple myeloma.
PMID 17417660·Bone Marrow Transplant·2007
3-trial
Randomized trial of an allogeneic melanoma lysate vaccine with low-dose interferon Alfa-2b compared with high-dose interferon Alfa-2b for Resected stage III cutaneous melanoma.
PMID 17513813·J Clin Oncol·2007
4-observational
Dye dilution proliferation assay: application of the DDPA to identify tumor-specific T cell precursor frequencies in clinical trials.
PMID 18161523·Immunol Invest·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 5014 JUDICIAL WAY
FREDERICK, MD 21703 - Phone
- (216) 559-6577
Quick Facts
- NPI
- 1275549073
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile